Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Common Equity of -$76.6 million for Q1 2026, down 245.33% year-over-year from $52.7 million in Q1 2025, and down 64.3% quarter-over-quarter from -$46.6 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Common Equity history runs 7 years deep, the most recent figure standing at -$76.6 million for Q1 2026.
- In Q1 2026, Common Equity fell 245.33% year-over-year to -$76.6 million; the TTM figure through Mar 2026 stood at -$76.6 million (down 245.33% YoY), while the FY2025 annual figure was -$46.6 million, down 164.93% from the prior year.
- Common Equity for Q1 2026 stood at -$76.6 million, down from -$46.6 million in the prior quarter.
- The five-year high for Common Equity was $186.6 million in Q2 2022, with the low at -$76.6 million in Q1 2026.
- The 5-year median for Common Equity is $135.8 million (2024), against an average of $98.8 million.
- The sharpest annual moves came in 2022 and 2026: Common Equity jumped 1188.41% in 2022, then slumped 245.33% in 2026.
- Ascend Wellness Holdings' Common Equity stood at $163.4 million in 2022, then retreated by 12.57% to $142.9 million in 2023, then sank by 49.74% to $71.8 million in 2024, then tumbled by 164.93% to -$46.6 million in 2025, then slumped by 64.3% to -$76.6 million in 2026.
- Business Quant data shows AAWH's Common Equity at -$76.6 million in Q1 2026, -$46.6 million in Q4 2025, and $8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 4.05 Bn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | -85.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -85.91 Mn |
| Mar 31, 2026 | -76.59 Mn |
| Dec 31, 2025 | -46.62 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 28.15 Mn |
| Mar 31, 2025 | 52.70 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 88.91 Mn |
| Jun 30, 2024 | 117.54 Mn |
| Mar 31, 2024 | 135.83 Mn |
| Dec 31, 2023 | 142.87 Mn |
| Sep 30, 2023 | 159.47 Mn |
| Jun 30, 2023 | 165.96 Mn |
| Mar 31, 2023 | 148.96 Mn |
| Dec 31, 2022 | 163.42 Mn |
| Sep 30, 2022 | 174.07 Mn |
| Jun 30, 2022 | 186.62 Mn |
| Mar 31, 2022 | 158.03 Mn |
| Dec 31, 2021 | 176.48 Mn |
| Sep 30, 2021 | 184.04 Mn |